Stay updated with breaking news from Nasdaq Bmea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) have been assigned an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 12-month price objective among brokerages that have issued a report on the stock […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) major shareholder A2a Pharmaceuticals, Inc. sold 25,000 shares of the stock in a transaction on Friday, May 12th. The shares were sold at an average price of $33.84, for a total transaction of $846,000.00. Following the completion of the transaction, the insider now owns 3,625,000 shares of the […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) was the target of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 6,080,000 shares, an increase of 28.5% from the April 15th total of 4,730,000 shares. Based on an average daily trading volume, of 866,700 shares, […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 6,080,000 shares, an increase of 28.5% from the April 15th total of 4,730,000 shares. Approximately 20.6% of the shares of the stock are short […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating)’s share price gapped up before the market opened on Friday . The stock had previously closed at $32.10, but opened at $33.40. Biomea Fusion shares last traded at $33.23, with a volume of 20,780 shares. Wall Street Analysts Forecast Growth BMEA has been the subject of a number […]